People
A look at six bay area-based VCs who are creating a lot of value in biotech.
Azar, the new HHS nominee, is being pitched as someone who will help lower the price of prescription drugs.
Every year, Forbes creates lists of “30 Under 30" leaders in various industries who are under the age of 30.
Alex Azar was head of U.S. operations for Lilly until January.
Gates to invest $50 million in the Dementia Discovery Fund and another $50 million in a number of start-up ventures working on Alzheimer’s research.
The company appointed former Celgene president Michael Pehl as CEO and Brendan Delaney as CCO.
Mr. Nagao complements the MediciNova Board with 40 years of experience in finance and corporate law with financial institutions in Japan.
President Donald Trump could be close to naming former Eli Lilly exec Alex Azar as new Secretary of HHS, according to reports.
The public listing is expected to value the business at around $46 billion.
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech.
PRESS RELEASES